Intraocular penetration of ketoconazole in rabbits.
We studied penetration of the antifungal agent ketoconazole into the cornea, aqueous humor, and vitreous of rabbits after topical, subconjunctival, and oral administration. The effect of debridement of corneal epithelium on penetration was also investigated. Ketoconazole levels in the cornea and aqueous humor were high after topical or subconjunctival administration, and increased markedly (especially in the cornea) if the corneal epithelium had been debrided before administration of the drug. For example, concentration of ketoconazole in the cornea 1 h after topical drug administration with or without complete corneal epithelial debridement was 44.0 +/- 10.1 and 1,391.5 +/- 130.0 micrograms/g, respectively. Drug levels in the vitreous were not detectable after topical or subconjunctival drug administration, but were improved slightly by prior epithelial debridement (8.3 and 0.12 micrograms/mL after 1 h, respectively). Orally administered ketoconazole resulted in high corneal concentrations (45.0 +/- 7.6 micrograms/g after 1 h) that were still substantial 24 h later (55.0 +/- 7.0 micrograms/g); levels in the aqueous were low.
Hemady
R K
RK
Cornea and Immunology Services, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston 02114.
Chu
W
W
Foster
C S
CS
D000284:Administration, Oral; D000287:Administration, Topical; D000818:Animals; D001082:Aqueous Humor / Q000378:metabolism*; D003228:Conjunctiva / Q000378:metabolism; D003315:Cornea / Q000378:metabolism*; D005260:Female; D007267:Injections; D007654:Ketoconazole / Q000008:administration & dosage / Q000493:pharmacokinetics*; D011817:Rabbits; D014822:Vitreous Body / Q000378:metabolism*
D007654:Ketoconazole